167 related articles for article (PubMed ID: 32163717)
1. The Fit fOR The Aged (FORTA) project and its clinical implications.
Pazan F; Wehling M
Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):275-277. PubMed ID: 32163717
[No Abstract] [Full Text] [Related]
2. [The FORTA (Fit fOR The Aged) List].
Pazan F; Wehling M
Inn Med (Heidelb); 2024 Jan; 65(1):3-8. PubMed ID: 38063911
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and deprescribing: just ask the patient.
Cave JA
Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
[No Abstract] [Full Text] [Related]
4. Assessing medication burden and polypharmacy: finding the perfect measure.
Gnjidic D; Tinetti M; Allore HG
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):345-347. PubMed ID: 28271722
[No Abstract] [Full Text] [Related]
5. Is my older cancer patient on too many medications?
Turner JP; Shakib S; Bell JS
J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
[TBL] [Abstract][Full Text] [Related]
6. Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study.
Michalek C; Wehling M; Schlitzer J; Frohnhofen H
Eur J Clin Pharmacol; 2014 Oct; 70(10):1261-7. PubMed ID: 25128076
[TBL] [Abstract][Full Text] [Related]
7. Methods to control the pharmaceutical cost impact of chronic conditions in the elderly.
Vivas-Consuelo D; Usó-Talamantes R; Trillo-Mata JL; Mendez-Valera P
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):425-37. PubMed ID: 25703585
[TBL] [Abstract][Full Text] [Related]
8. The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People.
Rabenberg A; Schulte T; Hildebrandt H; Wehling M
Drugs Aging; 2019 Oct; 36(10):969-978. PubMed ID: 31435913
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing: A simple method for reducing polypharmacy.
McGrath K; Hajjar ER; Kumar C; Hwang C; Salzman B
J Fam Pract; 2017 Jul; 66(7):436-445. PubMed ID: 28700758
[TBL] [Abstract][Full Text] [Related]
10. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
11. Reducing inappropriate polypharmacy: the process of deprescribing.
Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
[TBL] [Abstract][Full Text] [Related]
12. Prescribing issues in elderly individuals living with HIV.
Marzolini C; Livio F
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):643-659. PubMed ID: 31155978
[No Abstract] [Full Text] [Related]
13. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
[No Abstract] [Full Text] [Related]
14. [Good prescribing practice in the elderly].
Wickop B; Langebrake C
Ther Umsch; 2014 Jun; 71(6):366-73. PubMed ID: 24867351
[TBL] [Abstract][Full Text] [Related]
15. Clinical consequences of polypharmacy in elderly.
Maher RL; Hanlon J; Hajjar ER
Expert Opin Drug Saf; 2014 Jan; 13(1):57-65. PubMed ID: 24073682
[TBL] [Abstract][Full Text] [Related]
16. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
[TBL] [Abstract][Full Text] [Related]
17. Classic challenges and emerging approaches to medication therapy in older adults.
Alagiakrishnan K; Mah D; Padwal R
Discov Med; 2018 Oct; 26(143):137-146. PubMed ID: 30586537
[TBL] [Abstract][Full Text] [Related]
18. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification.
Wehling M; Burkhardt H; Kuhn-Thiel A; Pazan F; Throm C; Weiss C; Frohnhofen H
Age Ageing; 2016 Mar; 45(2):262-7. PubMed ID: 26786346
[TBL] [Abstract][Full Text] [Related]
19. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
